Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

santen pharmaceutical co.,ltd. - aflibercept (genetical recombination) - injection

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

bayer yakuhin, ltd. - aflibercept (genetical recombination) - injection

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

santen pharmaceutical co.,ltd. - aflibercept (genetical recombination) - injection

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

bayer yakuhin, ltd. - aflibercept (genetical recombination) - injection

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

santen pharmaceutical co.,ltd. - aflibercept (genetical recombination) - injection

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - aflibercept -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - brolucizumab -

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

bayer (pty) ltd û isando - injection - 40,0 mg - each 1,0 ml solution contains aflibercept 40,0 mg

Israel - English - Ministry of Health

sanofi - aventis israel ltd - aflibercept 25 mg/ml - concentrate for solution for infusion - zaltrap, in combination with 5-fluorouracil, leucovorin, irinotecan (folfiri), is indicated for adults with metastatic colorectal cancer (mcrc) that is resistant to or has progressed following an oxaliplatin-containing regimen.

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - ranitidine hcl eqv ranitidine - tablet, film coated - 150 mg - ranitidine hcl eqv ranitidine 150 mg